These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19691587

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Suppression of intimal hyperplasia with low molecular weight heparin in a sheep model.
    Ao PY, Hawthorne WJ, Coombs R, Fletcher JP.
    Int Angiol; 1999 Jun; 18(2):131-9. PubMed ID: 10424369
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel point-of-care assay for the monitoring of low-molecular weight heparins in the cardiac catheterization laboratory.
    Marmur JD, Lakhani M, El Rouby S, Cavusoglu E.
    J Invasive Cardiol; 2008 Sep; 20(9):449-54. PubMed ID: 18762674
    [Abstract] [Full Text] [Related]

  • 5. Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs.
    Babski DM, Brainard BM, Ralph AG, Pittman JR, Koenig A.
    J Vet Intern Med; 2012 Sep; 26(3):631-8. PubMed ID: 22435404
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A, Barbaste C, Gabaig AM, Trumel C, Abella-Bourges N, Guelfi JF, Bousquet Mélou A.
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A prospective trial that demonstrates that dalteparin requirements increase in pregnancy to maintain therapeutic levels of anticoagulation.
    Barbour LA, Oja JL, Schultz LK.
    Am J Obstet Gynecol; 2004 Sep; 191(3):1024-9. PubMed ID: 15467584
    [Abstract] [Full Text] [Related]

  • 11. Xa inhibition and coagulation activity--the influence of prolonged dalteparin treatment and gender in patients with acute coronary syndrome and healthy individuals.
    Oldgren J, Johnston N, Siegbahn A.
    Am Heart J; 2008 Mar; 155(3):493.e1-8. PubMed ID: 18294482
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
    Abou-Nassar K, Kovacs MJ, Kahn SR, Wells P, Doucette S, Ramsay T, Clement AM, Khurana R, Mackinnon K, Blostein M, Solymoss S, Kingdom J, Sermer M, Rey E, Rodger M, TIPPS investigators.
    Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Activated coagulation time in monitoring heparinized dogs.
    Green RA.
    Am J Vet Res; 1980 Nov; 41(11):1793-7. PubMed ID: 7212408
    [Abstract] [Full Text] [Related]

  • 20. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration.
    Marmur JD, Anand SX, Bagga RS, Fareed J, Pan CM, Sharma SK, Richard MF.
    J Am Coll Cardiol; 2003 Feb 05; 41(3):394-402. PubMed ID: 12575965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.